ISRCTN42625759已完成3 期
ational breast cancer study of Epirubicin plus CMF versus classical CMF Adjuvant Therapy
niversity of Birmingham (UK)0 个研究点目标入组 2,028 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2,028
研究概览
简要总结
- 2006 results in https://www.ncbi.nlm.nih.gov/pubmed/17079759 2. 2008 results in https://www.ncbi.nlm.nih.gov/pubmed/18797468 (added 25/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histological diagnosis of invasive breast cancer
- •2. Clinically early stage disease
- •3. Definitive surgery (either wide local excision or mastectomy) to the breast with complete excision of tumour
- •4. In the opinion of the clinician there is a definite indication for adjuvant chemotherapy, or the patient has been randomised to receive chemotherapy in the ABC study
- •5. Fit to receive chemotherapy in either of the two arms
- •6. No previous radiotherapy or chemotherapy
- •7. Adequate renal, hepatic and bone marrow function
- •8. Randomisation within 6 weeks of surgery, ideally within 1 month
- •9. No previous malignancy except, basal cell carcinoma or in situ carcinoma of the cervix
排除标准
- •Not provided at time of registration
研究者
相似试验
招募中
2 期
Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast CancerHER2-negative Breast CancerNeoadjuvant ChemotherapyNCT04576143Second Affiliated Hospital, School of Medicine, Zhejiang University260
已完成
3 期
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast CancerBreast CancerNCT00003577University Hospital Birmingham2,000
已完成
不适用
Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide RegenerationLocalized Breast CancerNCT05296317Centre Georges Francois Leclerc97
已完成
2 期
Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric CancerGastric CancerNCT00595972Fudan University25
招募中
2 期
A Study of Genetic Based Chemotherapy Dosing for Breast Cancer PatientsBreast NeoplasmsNCT01740271AHS Cancer Control Alberta48